Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Objective: To identify prognostic factors associated with survival time in HIV-infected patients with advanced immunodeficiency. Design: Prospective cohort study. Participants: A total of 1,284 HIV-infected patients with serial CD4 count measurements and at least one CD4 cell count ≤ 50 x 106/l (CD4 ≤ 50). Main outcome measure: Survival from initial CD4 cell count ≤ 50 x 106/l. Results: The median survival from initial CD4 ≤ 50 x 106/l was 17.1 months. The risk of death; increased by 2% [95% confidence interval (CI), 1-3] for each year of age, by 70% (95% CI, 3-16) for each 10 x 106/l decrease in CD4 count, and by 14% (95% CI, 9-18) for each 1 g/dl decrease in haemoglobin level. Compared to AIDS-free patients with CD4 ≤ 50 x 106 cells/l, the risk of dying was 1.5-fold (95% CI, 1.2-1.9) that of patients who had an AIDS diagnosis for fewer than 3 months prior to CD4 ≤ 50, 1.8-fold for patients with an AIDS diagnosis for 4-11 months prior to CD4 ≤ 50, and twice that of patients with AIDS for ≤ 12 months prior to CD4 ≤ 50. The risk of dying for patients whose rate of CD4 cell decline was > 40 x 106/l per 6 months was 1.7-fold (95% CI, 1.3-2.3) that of patients with an average CD4 cell loss ≤ 40 x 106/l per 6 months, after adjusting for age, haemoglobin and duration of AIDS prior to CD4 ≤ 50 x 106 cells/l. A prognostic score was developed from the final multivariate model, based on age at CD4 ≤ 50, haemoglobin at CD4 I 50, duration of AIDS and rate of CD4 decline prior to CD4 ≤ 50. Conclusions: Routinely available clinical and laboratory data including haemoglobin level, rate of CD4 decline and duration of AIDS can be readily translated into a prognostic score and then used to predict the survival experience of an HIV-infected patient with advanced immunodeficiency.

Original publication




Journal article



Publication Date





209 - 216